Aim: Serum gamma-glutamyl transferase (GGT) activity changes in response to oxidative stress. Metabolic syndrome (MetS) is associated with an increased risk of major cardiovascular events. Few data are available on the association between serum GGT and the prevalence of MetS among community-dwelling individuals in Japan. Methods: We recruited 793 men (mean age, 60 14 years), and 1,073 women (62 12 years), free from any history relating to cardiovascular disease during their annual health examination, from a single community. We performed a cross-sectional study to examine whether serum GGT was associated with MetS. Results: The levels of most confounding characteristics varied with increasing GGT activity. After adjustment for age, smoking status, drinking status, low-density lipoprotein cholesterol, uric acid, estimated glomerular filtration rate and alanine aminotransferase, the odds ratios (95% confidence interval) for MetS increased across serum GGT tertiles ( 
els, and medications 1, 2) . Elevated serum GGT activity is also a sensitive marker of oxidative stress 1) and is associated with cardiovascular disease (CVD) [3] [4] [5] . Serum GGT can also reflect other concomitant risk factors, such as obesity 6) , insulin resistance 7, 8) 
Introduction
Serum gamma-glutamyl transferase (GGT) is an enzyme that contributes to the extracellular catabolism of glutathione (GSH) 1) . The enzyme is present on cell surfaces and in serum, but most serum GGT is derived from the liver 2) . Serum GGT is a clinical marker of several factors: alcohol consumption, body fat content, plasma lipid/lipoproteins and glucose lev-common. MetS increases the risk of atherosclerotic disease, diabetes 17, 18) , and CVD 19) ; however, there are few reports on the relationship between serum GGT and MetS in Japan.
The aim of this study was to determine whether serum GGT is associated with MetS risk, and we examined cross-sectional data from Japanese community-dwelling participants.
Materials and Methods

Subjects
Participants were recruited at the time of their annual health examination in a rural town with a total population of 11,136 (as of April 2002) located in Ehime prefecture, Japan, in 2002. Among 9,133 adults aged 19 to 90 years in this population, 3,164 (34.6%) were assessed for eligibility to participate in the study. Information on medical history, present conditions, and medications was obtained by interview. The final study sample included 1,866 eligible individuals free from any history or symptoms of CVD. The Ethics Committee of Ehime University School of Medicine approved all procedures.
Evaluation of Risk Factors
Information on demographic characteristics and risk factors was collected using clinical files. Body mass index was calculated by dividing weight (in kilograms) by the square of the height (in meters). We measured blood pressure with an appropriately sized cuff on the right upper arm of the subjects using an automatic oscillometric blood pressure recorder (BP103i; Colin, Aichi, Japan) while seated after resting for at least 5 min. Cigarette smoking was quantified based on daily consumption and a history of smoking for subjects who reported smoking. Total cholesterol (T-C), triglycerides (TG), HDL-C, fasting blood glucose (FBG), creatinine (enzymatic method), uric acid, immuno-reactive insulin (IRI), alanine aminotransferase (ALT), and GGT were measured during fasting. Serum GGT concentration was assayed with an automatic analyzer (TBA-c6000, TOSHIBA, Tokyo) and the intraassay coefficient of variation was 0.87 to 2.11%. Low-density lipoprotein cholesterol (LDL-C) was calculated by the Friedewald formula 20) . Participants with TG ≥ 400 mg/dL were excluded (34 cases 21) . Participants with an eGFR 30 mL/min/ 1.73 m 2 were excluded (8 cases). Homeostasis of minimal assessment of insulin resistance (HOMA-IR) was calculated from FBG and IRI levels using the following formula; FBG {(mg/dL) IRI (mU/mL)}/405 22) .
Metabolic Syndrome
We applied condition-specific cutoff points for MetS based on the modified guidelines for the diagnosis of MetS in Japan 23) . Metabolic syndrome was defined as obesity with at least two of the following three conditions: hypertension, dyslipidemia, and impaired fasting glucose (IFG). Obesity was defined as a BMI ≥ 25.0 kg/m 2 24, 25) . Hypertension was defined as systolic blood pressure (SBP) ≥ 130 mmHg, diastolic blood pressure (DBP) ≥ 85 mmHg, or current treatment for hypertension. Dyslipidemia was defined as TG concentrations ≥ 150 mg/dL, low HDL cholesterolemia (HDL-C 40 mg/dL), or current treatment for dyslipidemia. IFG was defined as a FBG level ≥ 110 mg/dL or current treatment for diabetes mellitus.
Statistical Analysis
Statistical analyses were performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). Data are presented as the mean standard deviation (SD) unless otherwise specified, and parameters with non-normal distributions (TG, ALT, IRI, HOMA-IR, and GGT), the data are the median (interquartile range). In all analyses, parameters with non-normal distributions were used after log transformation. Differences among 3 groups divided based on tertiles of serum GGT ( 
Results
Subject Background Characteristics
The characteristics of the study participants in relation to sex are illustrated in Table 1 . The study included 793 men, aged 60 14 (range, 20 − 89) years, and 1,073 women, aged 62 12 (range, 21 − 88) years. Body mass index, smoking status, drinking status, SBP, DBP, TG, uric acid, ALT, FBG, and GGT were higher in men than in women, but age, HDL-C, LDL-C, antilipidemic medication, IRI, and HOMA-IR were higher in women. There was no inter-group difference in antihypertensive medication, eGFR, and diabetic medication.
Relationship between Clinical Characteristics and Tertiles of Serum GGT
As shown in Table 2 , tests for differences in characteristics across the three serum GGT levels were significant, except for the prevalence of antihypertensive and diabetic medications in both genders, and for age, smoking status, drinking status, and eGFR in women. In both genders, LDL-C, uric acid, ALT, IRI, HOMA-IR, BMI, DBP, TG, and FBG showed a linear trend in relation to serum GGT Men in higher GGT tertiles were younger, smokers, drinkers, and had elevated eGFR. HDL-C showed a U-shaped association with serum GGT in men and a downward trend in women. Women in higher GGT tertiles had elevated SBP, and a prevalence toward antilipidemic medication.
Relationship between HOMA-IR and Serum GGT
HOMA-IR significantly increased in correlation with an increase in serum GGT in both men (r 0.275) and women (r 0.337) (Fig. 1) . Table 3 shows the risk of MetS in relation to serum GGT among 793 men and 1,073 women. Of these, 125 men (15.8%) and 137 women (12.8%) had MetS. In both genders, the prevalence of MetS significantly increased in relation to serum GGT. After adjustment for age, smoking status, drinking status, LDL-C, uric acid, eGFR, and ALT, the odds ratio for MetS was 1.00, 2.23 (95% CI, 1.22 − 4.07), and 2.32 (95% CI, 1.18 − 4.56) in men, and 1.00, 1.43 (95% CI, 0.81 − 2.51), and 2.64 (95% CI, 1.50 − 4.64) in women, respectively. After additional adjustment for insulin resistance markers (IRI or HOMA-IR), the association was attenuated and the linear relation no longer significant in either gender.
Odds Ratio for MetS According to Tertiles of Serum GGT
Odds Ratio for Individual Components of MetS According to Tertiles of Serum GGT
The prevalence of individual components of MetS was significantly and linearly associated with increasing tertiles of serum GGT in both genders ( Table 4) . After adjustment for age, smoking status, drinking status, LDL-C, uric acid, eGFR, and ALT, serum GGT was significantly associated with the presence of individual components of MetS in both genders, except for dyslipidemia in men and hypertension in women.
Discussion
In this cross-sectional, population-based study, we determined the prevalence of MetS, as defined by modified Japanese criteria 23) , and examined the association between serum GGT and MetS and its components. MetS was common, occurring in 15.8% of men and 12.8% of women. Serum GGT levels were significantly associated with a risk for MetS and its components, except for dyslipidemia in men and hypertension in women, even after adjusting for age, smoking status, drinking status, LDL-C, uric acid, eGFR, and ALT. The OR of MetS dose-dependently increased from the upper normal range with increasing tertiles Metabolic syndrome: component conditions of the metabolic syndrome defined as obesity and two of the following conditions: hypertension, dyslipidemia and impaired fasting blood glucose. Model 1: non-adjusted; Model 2: adjusted for age; model 3: adjusted for age, smoking status, drinking status, low-density lipoprotein cholesterol, uric acid, estimated glomerular filtration rate, and log alanine aminotransferase; model 4: adjusted as described for model 2 plus log immuno-reactive insulin; model 5: adjusted as described for model 2 plus log homeostasis of minimal assessment of insulin resistance. GGT, gamma-glutamyl transferase. Table 4 . Adjusted odds ratio (95% CI) for each metabolic syndrome component according to tertiles of serum gamma-glutamyl transferase Characteristics Men, n 793 Women, n 1,073 of serum GGT. In addition, we demonstrated gender differences in MetS components with which serum GGT was independently associated.
In our study, higher GGT levels were positively associated with MetS, independent of other confounders. Similar results were found in a community-based cross-sectional study of 1,024 Caucasian adults, aged 40 to 59 years, in Finland 12) . Elevated GGT may not always relate to alcohol consumption, but may also indicate the existence of MetS 12) . In a pooled logistic analysis after adjustment for age, BMI, alcohol consumption, and gender, serum GTT (log-transformed GGT odds ratio 4.0, 95% CI 2.80 − 5.69) as well as BMI, uric acid, and T-C were independent contributors of MetS 12) . Moreover, Nakanishi et al. 10) also demonstrated that serum GGT may be an important predictor for developing MetS in 2,957 metabolic syndrome-free men and 3,260 nondiabetic men aged 35 − 59 years. After adjustment for age, family history of diabetes, BMI, alcohol intake, smoking status, regular physical activity, and white blood cell count, increased serum GGT was related to the risk of developing MetS, even among individuals with normal GGT concentrations, a finding consistent with previous prospective reports looking at GGT 10, 14) . Serum GGT is a sensitive indicator of alcohol consumption and/or liver dysfunction, such as fatty liver 1) , and is also high in patients with liver disease: chronic viral hepatitis, primary biliary cirrhosis (PBC), or drug induced liver injury. These liver diseases are present in community-dwelling individuals and are usually asymptomatic 26) ; hence, our study participants might Include patients with subclinical liver diseases. Nevertheless, the influence of these liver diseases might be small because patients with PBC were rare 26) , and those with viral hepatitis had already been identified during their annual health examination and treated. Further, the relationships between serum GGT and MetS persisted after adjusting for ALT. Of our enrolled patients, 87.1% of men and 35.8% of women drank alcohol, but MetS prevalence was similar in both genders, and the association between serum GGT and MetS persisted after adjusting for alcohol drinking; therefore, GGT may be an important biomarker for evaluating MetS risk.
In our study, serum GGT was significantly associated with the presence of individual components of MetS in both genders, excepting for dyslipidemia in men and hypertension in women, and was significantly lower in women than in men. It has been shown that the higher the baseline GGT level, the stronger the effect of age on the development of hypertension 27) ; thus, the well-described association between serum GGT and blood pressure might not be significant in women. Furthermore, serum GGT has also been shown to be more associated with hypertriglyceridemia and abnormal glucose tolerance among components of MetS, suggesting that serum GGT has a closer relationship with hepatic insulin resistance 13, 28) . In this study, serum GGT in men was not associated with dyslipidemia after adjustment; however serum GGT was significantly correlated with TG in multivariate analysis (data not shown).
The mechanisms by which GGT reflects the risk for MetS are not completely understood. Serum GGT was strongly associated with hypertension, dyslipidemia, and abnormal glucose tolerance, suggesting that elevated serum GGT accompanies hepatic insulin resistance, regardless of the presence of non-alcoholic fatty liver disease [28] [29] [30] . In our study, serum GGT levels were strongly associated with HOMA-IR, which is a reliable marker of insulin resistance, and after additional adjustment for HOMA-IR, the association between serum GGT and MetS was attenuated. Elevated GGT may also reflect inflammation, which impairs insulin signaling in the liver, muscle, and adipose tissues 31) . Fat accumulation in the liver or adipose tissues can induce inflammatory cytokines, such as tumor necrosis factor-, interleukin-6, and interleukin-8 32) . Higher c-reactive protein or white blood cells, which represent sub-clinical inflammatory processes, are associated with high GGT levels 24) . GGT also plays a direct role in LDL oxidation by hydrolyzing glutathione into more potent iron reductants 33) , and has an indirect role as a marker in antioxidant systems by maintaining the intracellular concentration of glutathione in response to oxidative stress 34) . Some limitatons of this study must be considered. First, our cross-sectional study design does not eliminate potential causal relationships between GGT and MetS. There remain important questions about the cumulative effects of these CVD risk factors over several decades and the interactions with other risk factors. Second, the prevalence of MetS and GGT categories is based on a single assessment of blood, which may introduce a misclassification bias. Third, we used BMI 25 to classify individuals with visceral obesity because waist circumference measurements were not available, which might have underestimated the effect of visceral obesity on MetS 35) . Fourth, the presence of viral hepatitis must be considered, but examinations of hepatitis B surface antigen and the antibody to hepatitis C were not performed; therefore, the demographics and referral source may limit generalizability.
In conclusion, the present study showed that serum GGT levels are strongly associated with MetS or its components in the general population. The underlying mechanism behind this relationship is unclear, but seems to be independent of traditional cardiovascular risk factors, such as age, smoking status, drinking status, LDL-C, uric acid, or renal function. For community-dwelling healthy individuals, prospective population-based studies are needed to investigate the mechanisms underlying this association to determine whether intervention, such as effective lifestyle modifications that decrease GGT in adults, will decrease MetS risks.
